All
 |
Unilife Corporation Announces Financial Results For Fiscal Year 2013 Third Quarter
May 9, 2013
|
286.8 KB |
|
| |
YORK, Pa., May 9, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended March 31, 2013, (the third quarter of Fiscal Year 2013).
Recent Highlights
In April, Unilife signed...
|
|
Unilife Corporation To Announce Financial Results For Fiscal 2013 Third Quarter On Thursday, May 9, 2013
Apr 22, 2013
|
11.1 KB |
|
| |
YORK, Pa., April 22, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2013 third quarter ended March 31, 2013 after market trading ends on Thursday, May 9, 2013.
Management has scheduled a conference call for 4:30 p.m. ...
|
|
Unilife Develops Unifill Assure™ to Enhance Patient Self-Injection of Biologics
Apr 18, 2013
|
14.0 KB |
|
| |
YORK, Pa., April 18, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced the development of the Unifill Assure™, a customized device from its Unifill® platform of ready-to-fill (prefilled) syringes that is designed to address unmet market needs for the injection of high-viscosity bi...
|
|
Unilife Signs Long-Term Customization and Commercial Supply Agreement for EZMix Dual Chamber Syringe
Apr 9, 2013
|
14.9 KB |
|
| |
YORK, Pa., April 9, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS) today announced the signing of a Customization and Commercial Supply Agreement with a U.S. pharmaceutical company (the "Customer") for the EZMix™ dual-chamber syringe.
(Photo: http://photos.prnewswire.com/prnh/20130409/NY910...
|
|
Unilife Corporation Announces Financial Results For Fiscal Year 2013 Second Quarter
Feb 11, 2013
|
23.8 KB |
|
| |
YORK, Pa., Feb. 11, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended December 31, 2012, (the second quarter of Fiscal Year 2013).
Highlights for the Fiscal Year 2013 Second Quart...
|
|
Unilife to Showcase Broad Portfolio of Innovative, Differentiated Injectable Drug Delivery Systems at Pharmapack Europe
Feb 11, 2013
|
13.2 KB |
|
| |
YORK, Pa., Feb. 11, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), a U.S. based designer, developer and supplier of injectable drug delivery systems, today announced it will exhibit at the Pharmapack Europe Annual Meeting in Paris, France between February 13th and 14th.
"Unilife is delighted to ...
|
|
Unilife Completes $10 Million Common Stock Offering
Feb 11, 2013
|
12.2 KB |
|
| |
YORK, Pa., Feb. 11, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS), a developer and commercial supplier of injectable drug delivery systems, today announced that it has completed the sale of common stock and warrants (the "Units") for gross proceeds of $10 million under a registered direct public offering...
|
|
Unilife Corporation To Announce Financial Results For Fiscal 2013 Second Quarter On Monday, February 11, 2013
Feb 6, 2013
|
10.7 KB |
|
| |
YORK, Pa., Feb. 6, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2013 second quarter ended December 31, 2012 after market trading ends on Monday, February 11, 2013.
Management has scheduled a conference call for 4:30...
|
|
Another U.S. Pharmaceutical Company Commences Unifill Stability Studies Aimed At Multiple Target Injectable Drugs
Dec 19, 2012
|
13.8 KB |
|
| |
YORK, Pa., Dec. 19, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS) today announced that another U.S. based pharmaceutical company has commenced stability and evaluation studies of the Unifill syringe for use with multiple injectable drugs.
The target drugs, which include both pipeline drugs as we...
|
|
Unilife Announces Results of 2012 Annual General Meeting
Nov 30, 2012
|
11.8 KB |
|
| |
YORK, Pa., Nov. 30, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that all four of the proposed items for its 2012 Annual General Meeting of shareholders were approved by the Company's shareholders.
The Company has posted a complete audio archive of the meeting, along with the...
|
|
Unilife to Present at the Lazard 9th Annual Healthcare Conference in New York City on November 13th
Nov 12, 2012
|
10.4 KB |
|
| |
YORK, Pa., Nov. 12, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that it will be presenting at the Lazard 9th Annual Healthcare Conference in New York City. Alan Shortall, Chief Executive Officer of Unilife, is scheduled to present at 2:30 p.m. EST on Tuesday, November 13, 2012.
...
|
|
Unilife Corporation Announces Financial Results For Fiscal Year 2013 First Quarter
Nov 8, 2012
|
20.9 KB |
|
| |
YORK, Pa., Nov. 8, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced financial results for the quarter ended September 30, 2012, (the first quarter of Fiscal Year 2013).
Recent Highlights:
The continued expansion of the Unilife proprietary portfolio of innovative, differenti...
|
|
Unilife's Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Drug Program
Nov 8, 2012
|
14.4 KB |
|
| |
YORK, Pa., Nov. 8, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that its Precision-Therapy™ platform of bolus injection systems has been selected by a global pharmaceutical company to enter the next stage of collaboration as its preferred choice for long-duration subcutaneous d...
|
|
Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
Oct 29, 2012
|
12.5 KB |
|
| |
YORK, Pa., Oct. 29, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that, due to severe weather conditions and expected power outages in the Northeastern region of the U.S., it has decided to reschedule the release of its results for the fiscal 2013 first quarter ended September 30, 2012. ...
|
|
Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
Oct 26, 2012
|
12.2 KB |
|
| |
New York, NY (October 26, 2012) - Griffin Securities announced today that the second part of its two-part interview series with Alan Shortall, CEO of Unilife Corporation ("Unilife") (NASDAQ: UNIS; ASX: UNS) is now available, during which Mr. Shortall discusses Unilife's device platforms and new commercial opportunities. The interview was...
|
|
Unilife Corporation To Announce Financial Results For Fiscal 2013 First Quarter On Tuesday, October 30, 2012
Oct 25, 2012
|
10.7 KB |
|
| |
YORK, Pa., Oct. 25, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2013 first quarter ended September 30, 2012 after market trading ends on Tuesday, October 30, 2012.
Management has scheduled a conference call for 4:3...
|
|
Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
Oct 25, 2012
|
12.7 KB |
|
| |
New York, NY (October 25, 2012) - Griffin Securities announced today that Dr. Keith Markey, the Scientific Director of Griffin's research division, recently interviewed Alan Shortall, CEO of Unilife Corporation ("Unilife") (NASDAQ: UNIS; ASX: UNS) about the company's continued progress in the commercialization of its portfolio of propriet...
|
|
Unilife Develops Breakthrough Device Technologies for Targeted Drug Delivery
Oct 16, 2012
|
16.0 KB |
|
| |
YORK, Pa., Oct. 16, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of two new breakthrough platform technologies for targeted drug delivery that can enable and enhance patient outcomes for many acute and chronic conditions where there are high rates of occurrence but li...
|
|
Unilife To Present Broad Portfolio of Injectable Drug Delivery Systems at Pre-Eminent Industry Conference
Oct 12, 2012
|
13.4 KB |
|
| |
YORK, Pa., Oct. 12, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that it will exhibit its portfolio of injectable drug delivery systems at the PDA Universe of Prefilled Syringes and Injection Devices being held in Las Vegas, Nevada between October 15 and 17.
Unilife will be ...
|
|
Unilife Expands Commercial Development Team as it Enters Next Phase of Customer Engagement
Oct 10, 2012
|
15.9 KB |
|
| |
YORK, Pa., Oct. 10, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the strategic expansion of its commercial development team, with the appointment of four senior executives from several leading companies in the drug delivery device market.
Mr. Alan Shortall, CEO of Unilife said...
|
|
|
